ONJEVADE Trademark

Trademark Overview

On Monday, October 5, 2020, a trademark application was filed for ONJEVADE with the United States Patent and Trademark Office. The USPTO has given the ONJEVADE trademark a serial number of 90234743. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 8, 2024. This trademark is owned by Merck Sharp & Dohme Corp.. The ONJEVADE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in Oncology
onjevade

General Information

Serial Number90234743
Word MarkONJEVADE
Filing DateMonday, October 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in Oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 18, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMERCK SHARP & DOHME LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressRAHWAY, NJ 07065
Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRahway, NJ 07065
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Monday, January 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 23, 2023ASSIGNED TO EXAMINER
Friday, May 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 24, 2023SOU EXTENSION 4 GRANTED
Wednesday, May 24, 2023SOU EXTENSION 4 FILED
Wednesday, May 24, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 7, 2022SOU EXTENSION 3 GRANTED
Monday, November 7, 2022SOU EXTENSION 3 FILED
Monday, November 7, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 22, 2022SOU EXTENSION 2 GRANTED
Wednesday, June 8, 2022SOU EXTENSION 2 FILED
Wednesday, June 29, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 16, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 8, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 8, 2021SOU EXTENSION 1 GRANTED
Wednesday, December 8, 2021SOU EXTENSION 1 FILED
Wednesday, December 8, 2021SOU TEAS EXTENSION RECEIVED
Thursday, June 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 10, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, June 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 8, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 2, 2021ASSIGNED TO EXAMINER
Wednesday, November 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 8, 2020NEW APPLICATION ENTERED

Related Keywords

onjevade oncology substances preparations pharmaceutical